Park Avenue Securities’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,816
Closed -$597K 1380
2023
Q3
$597K Buy
+2,816
New +$563K 0.01% 760
2023
Q1
Sell
-4,722
Closed -$607K 1201
2022
Q4
$607K Buy
4,722
+306
+7% +$39.5K 0.01% 711
2022
Q3
$604K Sell
4,416
-20
-0.5% -$3.26K 0.01% 644
2022
Q2
$785K Buy
4,436
+1,391
+46% +$200K 0.02% 556
2022
Q1
$439K Buy
3,045
+244
+9% +$33K 0.01% 795
2021
Q4
$433K Buy
2,801
+515
+23% +$86.2K 0.01% 776
2021
Q3
$388K Buy
2,286
+263
+13% +$40.9K 0.01% 754
2021
Q2
$319K Buy
2,023
+95
+5% +$14.1K 0.01% 811
2021
Q1
$268K Buy
+1,928
New +$311K 0.01% 819

Other funds holding SGEN

Park Avenue Securities's SGEN Position: Q4 2023 in Review

Park Avenue Securities sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 2,816 shares — an estimated $597K sold.

Park Avenue Securities first reported a position in SGEN in Q1 2021 and held it in 9 quarters. The position peaked at $785K in Q2 2022. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • Park Avenue Securities reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Park Avenue Securities sold 2,816 Seagen Inc. Common Stock shares in Q4 2023, an estimated $597K.
  • Park Avenue Securities first reported a position in Seagen Inc. Common Stock in Q1 2021 and held it in 9 quarters.
  • Park Avenue Securities's Seagen Inc. Common Stock position peaked at $785K in Q2 2022.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Park Avenue Securities's 13F filing for Q4 2023, filed 10 Jan 2024.